Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23466307 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatitis C Virus Chronic Infection
Intervention: Biological: CP 675,206

Indicates status has not been verified in more than two years